Related Experiment Video
Updated: Aug 9, 2026
12:04
Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
Published on: August 14, 2012
Thymic Neuroendocrine Neoplasms: Biological Behaviour and Therapy
Ru Jia1, Petra Sulentic, Jian-Ming Xu
1Department of Gastrointestinal Oncology, Affiliated Hospital Cancer Center, Academy of Military Medical Sciences, Beijing, China.
Neuroendocrinology
|March 30, 2017
Summary
Thymic neuroendocrine neoplasms are rare, aggressive tumors. Current management strategies are suboptimal, necessitating improved treatment approaches for these challenging endocrine neoplasms.
Area of Science:
- Endocrinology
- Oncology
- Pathology
Background:
- Thymic neuroendocrine neoplasms (tNENs) are rare tumors.
- Previously considered lung carcinoid variants, they exhibit greater aggressiveness and treatment difficulty.
- Associated with Multiple Endocrine Neoplasia-1 (MEN1) in 25% and ectopic ACTH syndrome.
Purpose of the Study:
- To discuss the classification and known biology of tNENs.
- To review clinical, biochemical, and imaging features of these neoplasms.
- To explore and suggest optimized management strategies for tNENs.
Main Methods:
- Literature review on thymic neuroendocrine neoplasms.
- Analysis of classification, biology, and clinical presentation.
- Evaluation of current and potential treatment options.
Main Results:
- tNENs are distinct from lung carcinoids, presenting higher aggressiveness.
- Significant associations with MEN1 and ectopic ACTH syndrome are noted.
- Current treatment outcomes are suboptimal, indicating a need for improved management.
Conclusions:
- Thymic neuroendocrine neoplasms require specialized management due to their aggressive nature.
- Further research and optimized treatment strategies are crucial for improving patient outcomes.
- Understanding the unique biology and associations of tNENs is key to effective therapy.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.